Of note, in vivo evaluations were carried out using the fully syngeneic B16 melanoma models and PD-L1-overexpressing B16 melanoma models as well as colon MC38 cell line-established adenocarcinoma model in immunocompetent mice [119]. The gene discussed is CD274; the disease is melanoma.